MedTrace Logo

Positive Expiratory Pressure During Inhalation of Hypertonic Saline in Patients With Cystic Fibrosis

NCT02303808 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2015-12-02

No results posted yet for this study

Summary

This trial aims to analyze whether the inhalation of hypertonic saline combined with a positive expiratory pressure (PEP) device increases the amount of sputum expectorated during the chest physiotherapy session ( inhalation + bronchial drainage).

Conditions

Interventions

DEVICE

INHALATION WITH PEP DEVICE (Acapella Duet)

Intervention will be performed during 5 consecutive days. The performance order of both arms will be randomized.

Sponsors & Collaborators

  • Universidad San Jorge

    lead OTHER

Principal Investigators

  • Marta San Miguel · Universidad San Jorge

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2015-11-30
Completion
2015-11-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02303808 on ClinicalTrials.gov